ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,835Medicare Part D Prescriptions Filled, Including Refills

Rank: 420 out of 3593

$384K Total Retail Price of All Prescriptions

Rank: 1014 out of 3593

644 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
20% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 644 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

11% of this provider’s 644 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 9,886 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$32 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
OMEPRAZOLE 612 522 1 5
AMLODIPINE BESYLATE 575 515 2 3
LEVOXYL 506 460 3 111
LISINOPRIL 501 438 4 2
SIMVASTATIN 462 421 5 1
PRAVASTATIN SODIUM 394 316 6 13
HYDROCHLOROTHIAZIDE 377 323 7 10
ENALAPRIL MALEATE 366 324 8 38
METOPROLOL TARTRATE 366 345 8 8
METFORMIN HCL 284 238 10 6
HYDROCODONE-ACETAMINOPHEN 268 190 S3 11 7
PANTOPRAZOLE SODIUM 256 190 12 45
FUROSEMIDE 255 209 13 9
ATORVASTATIN CALCIUM 225 190 14 15
LOVASTATIN 213 179 15 20
ALENDRONATE SODIUM 201 190 16 22
ZOLPIDEM TARTRATE 188 152 17 12
SPIRIVA 184 140 18 87
ATENOLOL 179 173 19 11
GLIPIZIDE 152 117 20 40
LOSARTAN POTASSIUM 138 118 21 14
K-TAB 136 114 22 217
TAMSULOSIN HCL 129 115 23 33
TRAMADOL HCL 125 93 24 17
PREDNISONE 123 112 25 49
CARVEDILOL 121 100 26 23
KLOR-CON 8 110 89 27 244
GABAPENTIN 105 66 28 16
OXYCODONE-ACETAMINOPHEN 104 93 S2 29 93
TRIAMTERENE-HCTZ 99 99 30 66
DILTIAZEM 24HR CD 95 70 31 173
FLUTICASONE PROPIONATE 92 69 32 32
ALLOPURINOL 86 75 33 35
CHLORTHALIDONE 86 75 33 227
LEVOTHYROXINE SODIUM 86 62 33 4
SERTRALINE HCL 81 59 36 28
VERAPAMIL ER 79 69 37 99
AZITHROMYCIN 70 59 38 34
WARFARIN SODIUM 69 59 39 18
LANOXIN 68 64 40 223
CYMBALTA 66 53 41 73
MICARDIS 66 59 41 336
CIPROFLOXACIN HCL 62 59 43 52
METFORMIN HCL ER 62 48 43 67
LEVOFLOXACIN 55 48 45 116
AMITRIPTYLINE HCL 54 48 R 46 90
FLUOXETINE HCL 54 39 46 60
NIFEDIPINE ER 54 51 46 75
VENTOLIN HFA 53 35 49 80
CLONIDINE HCL 52 43 50 41
AMOX TR-POTASSIUM CLAVULANATE 51 36 51 138
OXYBUTYNIN CHLORIDE 50 45 52 104
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 11, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.